Impact of elevated body mass index on cumulative live birth rate and obstetric safety in women undergoing assisted reproductive technology

Dan Hu, Bo Huang, Min Xiong, Junning Yao, Shulin Yang, Ruxing Wu, Hanwang Zhang, Yiqing ZhaoScientific 2022 · DOI

TL;DR

While age is the primary driver of fertility, a high Body Mass Index (BMI) significantly reduces the cumulative live birth rate and increases obstetric risks—but primarily for younger women. In women over 38, the biological impact of aging appears to "mask" the adverse effects of weight, suggesting that weight loss interventions are most critical for younger patients entering IVF.

What Problem Does This Paper Address?

The impact of obesity on Assisted Reproductive Technology (ART) has long been a subject of debate. While some studies suggest that an elevated BMI hinders success, others show no significant difference in outcomes. Most existing research focuses on "fresh" cycles (the first attempt after egg retrieval), which provides an incomplete picture.

This study addresses two major gaps:

  1. Cumulative Success: It looks at the Cumulative Live Birth Rate (CLBR), which accounts for all embryos generated from a single egg retrieval (including subsequent frozen transfers). This is a much more robust metric for a patient's total reproductive potential.
  2. Obstetric Safety: It extends the analysis beyond the laboratory to look at the health of the mother and the infant, including pregnancy complications and birth defects.

Methods

The researchers conducted a large-scale retrospective cohort study at a single center in China, analyzing data from 7,229 patients treated between 2014 and 2020.

To minimize "noise" in the data, they:

  • Standardized the Protocol: Only included patients on a routine "long" gonadotropin-releasing hormone (GnRH) agonist protocol.
  • Categorized by BMI: Divided patients into "Normal" (18.5–24.9 kg/m²) and "High" (≥25 kg/m²) groups.
  • Stratified by Age: Analyzed younger women (<38 years) and older women (≥38 years) separately to account for the steep decline in fertility that occurs in the late 30s.
  • Multivariate Analysis: Used logistic regression to determine if BMI was an independent risk factor for failure, controlling for variables like the number of oocytes retrieved and antral follicle count (AFC).

Datasets

The study utilized a clinical dataset from the Reproductive Medicine Center of Tongji Hospital in Wuhan, China.

  • Total Patients: 7,229 women.
  • Follow-up: Patients were tracked through May 2020, until they either achieved a live birth or exhausted all embryos from their first stimulation cycle.
  • Birth Defect Data: Collected via telephone follow-up one month after delivery.

Key Insights and Ideas

  • The "Age Equalizer": The most striking finding is that BMI's negative impact vanishes in older women (≥38). The authors suggest that age-related egg quality decline is such a dominant factor that it effectively "drowns out" the metabolic interference caused by high BMI.
  • Oocyte Quantity vs. Quality: In younger women, high BMI was associated with fewer retrieved oocytes and fewer available embryos. However, the quality of the embryos that did make it (measured by high-quality embryo rates) wasn't significantly different. This suggests the primary hit is to the "ovarian response"—the body's ability to produce eggs in response to stimulation.
  • The Safety Gap: Even when younger women with high BMI did achieve a live birth, they faced higher risks. The study found a significant increase in Hypertensive Disorders of Pregnancy (HDP), fetal macrosomia (excessive birth weight), and specific birth defects like cleft lip and palate.

Key Results

For younger women (<38 years), the high BMI group showed:

  • Reduced Success: A lower CLBR (73.7% vs. 76.8%, P=0.034).
  • Higher Obstetric Risk: Nearly triple the rate of hypertensive disorders (4.4% vs. 1.5%).
  • Increased Delivery Intervention: A significantly higher C-section rate (90.8% vs. 83.1%).
  • Statistical Risk: Multivariate analysis showed that high BMI reduced the odds of a cumulative live birth by approximately 19% (OR 0.809).

In contrast, for the older subgroup (≥38 years), there were no statistically significant differences in any of these primary outcomes between the normal and high BMI groups.

Limitations and Future Work

  • Cohort Composition: The study was conducted in a Chinese population where the proportion of "obese" (BMI ≥30) individuals is relatively low compared to Western populations. Most of the "High BMI" group were in the "overweight" category.
  • Retrospective Nature: As a retrospective study, it can show correlation but not definitive causation.
  • Birth Defect Reporting: Data on birth defects was collected via telephone, which may lead to underreporting of minor issues.
  • Future Directions: The authors call for randomized controlled trials (RCTs) to determine if weight loss interventions before IVF actually improve these cumulative outcomes, particularly to see if the "safety gap" can be closed for younger women.

Summary updated

Abstract

This study evaluated the impact of elevated body mass index (BMI) on short- and long-term outcomes of in-vitro fertilization (IVF)/intracytoplasmic sperm injection (ICSI) treatments. A total of 7229 patients undergoing IVF/ICSI fresh cycles and subsequent frozen embryo transfer cycles from 2014 to 2020 were divided into normal (18.5-24.9 kg/m<sup>2</sup>) and high BMI (≥ 25 kg/m<sup>2</sup>) groups. Ovarian response, pregnancy outcomes, and safety of both mother and fetus were the main outcome measures. Furthermore, multivariate analysis was used to determine whether BMI was associated with cumulative live birth rate (CLBR). Results showed that for younger women (< 38 year), CLBR was significantly reduced in the high BMI group compared with the normal BMI control and was accompanied by fewer retrieved oocytes and available embryos. Additionally, the incidence of hypertensive disorders of pregnancy, fetal macrosomia, and cleft lip and palate birth defects resulting from cumulative live births was significantly higher compared with the normal BMI group. No differences were observed among older women (≥ 38 year). Multivariate analysis revealed that high BMI was a risk factor for CLBR. Our study suggested that elevated BMI has a greater adverse impact on younger women.
BibTeX
@inproceedings{hu2022impact,
  author = {Dan Hu and Bo Huang and Min Xiong and Junning Yao and Shulin Yang and Ruxing Wu and Hanwang Zhang and Yiqing Zhao},
  title = {{Impact of elevated body mass index on cumulative live birth rate and obstetric safety in women undergoing assisted reproductive technology}},
  booktitle = {Scientific},
  year = {2022},
  doi = {10.1038/s41598-022-23576-0},
}
Figure